Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused.
Australian health systems must rise to the challenge of providing thrombolysis to more stroke patients.
Davis
Stephen M
SM
Hand
Peter J
PJ
Donnan
Geoffrey A
GA
D002545:Brain Ischemia / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator